General. Cultivation of Photorhabdus luminescens TT01 and its plasmid integration mutants plu2237::cat and plu2076::cat was performed as described previously [1] [2] [3] with the appropriate antibiotics in the following concentrations: ampicillin 100 µg/ml, chloramphenicol 20 µg/ml, rifampicin 50 µg/ml. Natural product analysis by HPLC-MS/MS and HRESI-MS/MS [4] [5] [6] , natural product quantification in LB and Galleria mellonella [3] , and inhibition of JHEH [7] and JHE [8, 9] from Manduca sexta were performed as described previously. Bioactivity against Escherichia coli, Micrococcus luteus, Bacillus subtilis, Saccharomyces cerevisiae was performed as described [10] . Quorum quenching assays have also been described previously [11] . Phylogenetic analysis of Photorhabdus was performed as described [12] and all strains listed in Figure 4 were cultivated and analyzed by HPLC/MS as described previously [2, 3, 6] .
larvae that were infected with a suspension of P. luminescens TT01 cells. For this, an overnight culture of TT01 was washed with LB and adjusted to an optical density of OD 600 1.0 and each larva was injected by syringe in the midabdominal proleg with 5 µl of cell suspension. Aseptic LB medium was used as a control. All infected larvae were dead after 48 hours, while 95% of the control group survived. Each sample was snap-frozen in liquid nitrogen. The frozen larvae were ground to a crude powder using a pestle and mortar. The powder was extracted for 1 hour with 50 mL of a methanol/acetone (1:1) solvent mixture, filtered and evaporated. The crude extract was re-dissolved in 3 mL of methanol and diluted 1:10 before HPLC-MS analysis. Production kinetics were analysed using triplicates in LB broth. P. luminescens TT01 was cultivated in 1 L Erlenmeyer flasks containing 100 mL LB using the described cultivation conditions. For each time point 4 mL of culture broth was extracted with the same solvent mixture, filtered and the solvents removed under reduced pressure. The crude extract was then dissolved in 1 mL methanol and without further dilution submitted to HPLC-MS analysis.
Construction of the carbamoyl transferase and the methyl transferase mutants.
Carbamoyl transferase and methyl transferases encoded in the genome of P. luminescens TT01 [13] were identified using their homology to known enzymes from E. coli and by comparison between all Xenorhabdus [14, 15] and Photorhabdus [13, 16] genomes currently available. The genes plu2076 and plu2237 were only present in P. luminescens and encode a carbamoyl transferase and a methyl transferase, respectively. They were disrupted by plasmid integration as described previously. Briefly, the suicide vector pDS132 [17] or pCKcipB (a pDS132 derivative with an additional BglII recognition site) both carrying a chloramphenicol resistance gene (cat) were used. An internal fragment of plu2237 (pliB) was amplified with λpir phage lysogen). Subsequently this construct was conjugated into a rifampcin-resistant TT01 strain as previously described [1] .
The plasmid donor strain and the acceptor strain were grown to an OD 600 of 0.6-0.8 and spotted together (in a ration of 1:3) onto a LB agar plate without any selection marker. Cells were incubated at 37°C for 3 h and another 21 h at 30°C. The cell lawn was harvested using an inoculation loop and resuspended in 2 ml LB medium. For selection of TT01 colonies with acquired chloramphenicol resistance different volumes of the cell suspension (50 µl, 100 µl and 200 µl) were plated on LB agar plates with rifampicin and chloramphenicol. The genotype of the chloramphenicol resistant strain TT01-2237::cat was confirmed by PCR using a plasmid-specific pair of primers pDS132fw (5'-GATCGATCCTCTAGAGTCGACCT-3') and pDS132rv (5'-ACATGTGGAATTGTGAGCGG-3') in combination with a genomespecific pair of primers V_KO_plu2237_fw (5´-GAGCGATTCTGGCTAAATCG-3´) and
V_KO_plu2237_rev (5´-TTGATGTTTACGGCGATGG-3´).
For the generation of the plu2076 (pliA) insertion mutant in P. luminescens the same approach was applied: An internal fragment of plu2076 was amplified with the primers KOplu2076SacI (5´-AATGCTGAGCTCACGTTTTCTGCGAGAGAATAATCCA-3´) containing a SacI restriction side (bold) and KOplu2076PaeI (5´-ATATTCGCATGCCATTATCAAATGCTGGCGGTAAC-3´) containing a PaeI restriction side (bold) which yielded a product of 740 bp that was then subcloned into vector pJET1.2 and subsequently cloned into pDS132 via the SacI and PaeI restriction sites. The resulting plasmid pDS2076KO was introduced into E. coli S17-1 λpir by electroporation and the P.
luminescens plasmid insertion mutant TT01-2076::cat was generated as described. The correct plasmid insertion was confirmed by PCR using again the plasmid-specific primers pDS132fw and pDS132rv as well as genomic-specific primers V2076_Fw (5´-TTCGCTAGAAGCACCGCATT-3´) and V2076_Rv (5´-TCAGCAAAGTTGCGCAAAGC-3´).
Comparison of in vivo virulence of P. luminescens WT and pliA mutant. P. luminescens wt and pliA mutant were grown overnight in LB broth with shaking at 28°C in the dark. Subcultures were grown to mid exponential phase (OD 600 = 0.2-0.4). Dilutions of bacteria where then injected into first day 5 th instar Manduca sexta larvae, which were reared as previously described [18] . Briefly, larvae were maintained individually at 25˚C under a photoperiod of 17 hours light: 7 hours dark and fed on an artificial diet based on wheat germ. Unless otherwise stated, larvae 1 day after ecdysis to the 5th instar were used for all experiments.
For the two strains approximately 100, 1000 and 10000 viable cells (confirmed by overnight plating) were injected into a cohort of 12 animals each, which were then monitored for mortality (movement and turgidity) by regular physical stimulus over 3 days and again at 7 days.
Determination of antimicrobial peptide transcript levels in Galleria mellonella and
Manduca sexta. Stock solutions of the different phurealipids were prepared by dissolving the compounds separately in 100% ethanol. For injection, 1:100 dilutions of individual compound were used for injection. The concentrations injected were as follows: 1 (46 µg/ml), 2 (28 µg/ml), 3 (28 µg/ml), 4 (31 µg/ml), 5 (28 µg/ml), 6 (28 µg/ml), 7 (22 µg/ml), 8 (28 µg/ml), 9
(28 µg/ml), 10 (28 µg/ml), 12 (28 µg/ml), and 13 (44 µg/ml).
Larvae of G. mellonella were reared at 32°C in darkness and on an artificial diet (22% maize meal, 22% wheat germ, 11% dry yeast, 17.5% bees wax, 11% honey, 11% glycerin). Lastinstar larvae, each weighing 250-350 mg, were used in all experiments as described previously [19] [20] [21] .
To induce immune responses in G. mellonella larvae were injected with the Data were analyzed as described previously [22] . Briefly, Ct values were normalized by calculating the ratio between the reference gene and the gene of interest and presented as a ratio between infected versus PBS injected larvae. Data were statistically analyzed using nm Argon laser (100 mW initial power, 30%), images were recorded through an EC Plan-Neofluar 10×/0.30 M27 objective (#420341-9910-000, Carl Zeiss, Göttingen, Germany) with a Rolera EM-C² camera (#01-ROL-EMC2-R-F-M-14-C, QImaging, Surrey, BC, Canada).
Each embryo was imaged in 6 planes with 30 µm spacing and a 200 ms exposure time.
Imaging was performed over a period of 50:00 hours with an interval of 00:15 hours. The stage speed was reduced to 10% of the maximum to prevent embryos from detaching. From the recorded planes per embryo, maximum projections were computed and embryos were rotated with their anterior pole to the top.
Statistics. Four datasets with 6 PBS control embryos, 6 DMSO control embryos and 12 embryos for each compound/concentration were recorded. Embryos that completed dorsal closure properly were scored as completing the development. Significance was determined by the two-sided student's t-test.
Chemical synthesis of glycine amides and phurealipids.
If not noted differently, the chemicals were purchased in the highest purity available.
General synthetic procedure I. 1 eq of the corresponding isocyanides were dissolved in acetone (4 mL/mmol) and 2 eq of the amine were added. The reaction mixture was stirred overnight and the forming precipitate recrystallized.
General synthetic procedure II. 1 eq of the free acid was dissolved in benzene (45 mL/mmol) and 6 eq of triethylamine and 3 eq of diphenylphosphoryl azide were added. After refluxing for approximately 1h the reaction mixture was cooled to room temperature, acetone (30 mL/mmol) and ca. 10 eq of methylamine (40% in water) or ammonium hydroxide (28 -30% in water) were added and the mixture stirred at room temperature overnight. The solvents were removed under reduced pressure and the precipitate purified with normal phase liquid chromatography or recrystallization.
General synthetic procedure III (synthesis of glycine amides). 1 eq of Boc-protected glycine was dissolved in dichloromethane (3 mL/mmol), cooled to 0°C and 1.1 eq of TBTU and 4 eq DIEA were added slowly. After stirring of 10 min at 0°C the reaction mixture was warmed to room temperature and 1.1 eq of the corresponding amine were added and stirred overnight. Upon completion of the reaction the organic phase was washed with a saturated ammonium chloride solution. The resulting aqueous phase was extracted three times with dichloromethane, then the organic phases were combined and dried over sodium sulfate. The solvents were removed under reduced pressure and the precipitate purified with normal phase liquid chromatography. The protecting group was removed quantitatively upon incubation with 4 M hydrochloric acid in dioxane (10 mL/mmol) at 0°C for several hours. Then the solvents were removed under reduced and the target compound was obtained as a hydrochloric salt. N'-(9-methyldecyl) urea (1) was obtained according to the general procedure II.
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N-Methyl-
The iso-branched fatty acid was purchased with Larodan AB (Limhamn, Sweden).
Recrystallization from acetone yielded the white crystalline urea (15 mg, 0.066 mmol, 65% yield 
12
N-nonyl urea (12) [25, 26] was obtained according to the general procedure II. Recrystallization from acetone yielded yielded the white crystalline urea (18.5 mg, 0.099 mmol, 19% yield). Table S1 . Structure elucidation of the phurealipids A, C, D (1, 3, 4 ) and the desmethyl phurealipids B, E, F (2, 5, 6) . The desmethyl derivatives 5
and 6 were only produced in the pliB mutant. Feeding of deuterated leucine resulted in the expected 2 H 7 -shift in 1-3 and 5 from the incorporation of 
